BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10089952)

  • 1. A case of advanced esophageal cancer showing a long-term complete response with chemotherapy with nedaplatin alone.
    Satoh T; Tsushima K; Saitoh S; Hizawa Y; Tamura Y; Fukuda S; Yamada Y; Tohno H; Takasugi T; Sakata Y; Munakata A
    Jpn J Clin Oncol; 1999 Feb; 29(2):106-8. PubMed ID: 10089952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Nedaplatin combined with tegafur in the treatment for advanced esophageal cancer].
    Fan QX; Wang R; Lu P; Zhao YF; Lu TY; Han JW; Wang JS; Luo SX; Lu SP; Wang GJ; Geng L; Zhang MZ; Ma ZY; Song M; Wu XA; Chen XB; Jiao ZM; Wang RL
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):937-9. PubMed ID: 19173998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I Study of Docetaxel Plus Nedaplatin in Patients With Metastatic or Recurrent Esophageal Squamous Cell Carcinoma After Cisplatin Plus 5-Fluorouracil Treatment.
    Kajiura S; Hosokawa A; Yoshita H; Ueda Y; Ueda A; Mihara H; Ando T; Fujinami H; Nishikawa J; Ogawa K; Minemura M; Sugiyama T
    Am J Clin Oncol; 2016 Feb; 39(1):13-7. PubMed ID: 24322336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of a 14-month survival patient on advanced esophageal cancer with uncontrolled brain metastasis completely responding to nedaplatin, adriamycin, plus 5-FU (NAF) therapy].
    Iijima S; Makari Y; Kato T; Ooshima S; Hoshi M; Doi T; Miyake Y; Sakamoto T; Kato A; Miyo M; Kurokawa E; Kikkawa N
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2052-4. PubMed ID: 20037320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Biweekly Docetaxel in Combination with Nedaplatin as Second-line Chemotherapy for Unresectable or Recurrent Esophageal Cancer.
    Kanekiyo S; Takeda S; Nakajima M; Nishiyama M; Kitahara M; Shindou Y; Michihisa I; Abe T; Yoshino S; Hazama S; Nagano H
    Anticancer Res; 2016 Apr; 36(4):1923-7. PubMed ID: 27069181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of inoperable esophageal carcinoma with hepatic and nodal metastases which showed a long-term survival after chemoradiotherapy including nedaplatin.
    Sumi H; Ohtsu A; Boku N; Muto M; Nagashima F; Hosokawa K; Yoshida S; Satake M; Ishikura S; Ogino T
    Jpn J Clin Oncol; 2000 Sep; 30(9):406-9. PubMed ID: 11095139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II study of paclitaxel and nedaplatin as front-line chemotherapy in Chinese patients with metastatic esophageal squamous cell carcinoma.
    He YF; Ji CS; Hu B; Fan PS; Hu CL; Jiang FS; Chen J; Zhu L; Yao YW; Wang W
    World J Gastroenterol; 2013 Sep; 19(35):5910-6. PubMed ID: 24124338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and feasibility of ambulatory treatment-based monthly nedaplatin plus S-1 in definitive or salvage concurrent chemoradiotherapy for early, advanced, and relapsed esophageal cancer.
    Yamashita H; Haga A; Takenaka R; Kiritoshi T; Okuma K; Ohtomo K; Nakagawa K
    Radiat Oncol; 2016 Jan; 11():4. PubMed ID: 26781439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phase II multicenter clinical trial of nedaplatin in the treatment of malignant tumors].
    Zhang P; Feng FY; Wu LY; Hu Y; Liu JW; Gao YJ; Guan XQ; Nan KJ; Suo AL; Wang XW; Zhang MH; Zhang WD; Li CW; Zhang Y; Zhao JB
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):230-4. PubMed ID: 16875614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II study of paclitaxel and nedaplatin as first-line chemotherapy in patients with advanced esophageal cancer.
    Cao W; Xu C; Lou G; Jiang J; Zhao S; Geng M; Xi W; Li H; Jin Y
    Jpn J Clin Oncol; 2009 Sep; 39(9):582-7. PubMed ID: 19509000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of cisplatin-based versus nedaplatin-based regimens for the treatment of metastatic/recurrent and advanced esophageal squamous cell carcinoma: a systematic review and meta-analysis.
    Zhang F; Wang Y; Wang ZQ; Sun P; Wang DS; Jiang YX; Zhang DS; Wang FH; Xu RH; Li YH
    Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 27868295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of advanced esophageal cancer with multiple lymph node metastases successfully treated with induction chemotherapy consisting of nedaplatin and 5-FU followed by chemoradiotherapy].
    Sasaki T; Nakamura K; Toba T; Kimura M; Ohga S; Urashima Y; Terashima H; Masuda K
    Gan To Kagaku Ryoho; 2002 Aug; 29(8):1417-20. PubMed ID: 12214470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docetaxel, nedaplatin, and S-1 (DGS) chemotherapy for advanced esophageal carcinoma: a phase I dose-escalation study.
    Tanaka Y; Yoshida K; Osada S; Yamaguchi K; Takahashi T
    Anticancer Res; 2011 Dec; 31(12):4589-97. PubMed ID: 22199335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phase II clinical trial of home-produced Nedaplatin in treating advanced esophageal carcinoma].
    Xu RH; Shi YX; Guan ZZ; Jiang WQ; Huang H; Ma ZY; Wang JH; Hu XH; Xie WM; Li XG; Liu YL; Pan LX; Dai AD; Zhuang W; Zhang C
    Ai Zheng; 2006 Dec; 25(12):1565-8. PubMed ID: 17166388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of advanced esophageal cancer with para-aortic lymph node metastasis with complete response (CR) to combination chemotherapy including nedaplatin].
    Noda S; Kubo N; Tanaka H; Muguruma K; Yashiro M; Yamada N; Maeda K; Sawada T; Ohira M; Ishikawa T; Hirakawa K
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2451-3. PubMed ID: 20037453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination chemotherapy with docetaxel and nedaplatin for recurrent esophageal cancer in an outpatient setting.
    Osaka Y; Takagi Y; Hoshino S; Tachibana S; Tsuchida A; Aoki T
    Dis Esophagus; 2006; 19(6):473-6. PubMed ID: 17069591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of combined docetaxel and nedaplatin chemotherapy for recurrent esophageal cancer compared with conventional chemotherapy using cisplatin and 5-fluorouracil: a retrospective study.
    Fujita Y; Hiramatsu M; Kawai M; Sumiyoshi K; Nishimura H; Tanigawa N
    Dis Esophagus; 2008; 21(6):496-501. PubMed ID: 18840134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neoadjuvant chemotherapy for esophageal cancer by administration of nedaplatin alone].
    Hirata S; Yatsuyanagi E; Yamazaki H; Sugimoto Y; Kosiko S; Kokubo T; Atsuta Y; Sasajima T; Miyokawa N
    Gan To Kagaku Ryoho; 2000 Feb; 27(2):221-6. PubMed ID: 10700891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Concurrent chemoradiotherapy with nedaplatin and 5-fluorouracil (5-fu) for locally advanced squamous cell carcinoma of the esophagus].
    Kubo N; Morimoto J; Tanaka H; Ohira M; Noda E; Amano R; Inoue T; Yamada N; Yashiro M; Maeda K; Yamashita Y; Muguruma K; Sawada T; Hirakawa K
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):1997-9. PubMed ID: 20037303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective study of paclitaxel combining nedaplatin chemotherapy for esophageal cancer.
    Du J; Hu C; Zhang Y; Hu B; Wang F; Zhang Y
    Anticancer Drugs; 2015 Jan; 26(1):101-5. PubMed ID: 25222530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.